)

Pediatrix Medical Group (MD) investor relations material
Pediatrix Medical Group Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Adjusted EBITDA for Q2 2025 exceeded expectations at $73.2M, driven by over 6% same-unit revenue growth, strong hospital-based volume, and favorable reimbursement factors.
Net revenue for Q2 2025 was $468.8M, down 7% year-over-year due to practice dispositions, but same-unit revenue increased 6.4% from higher patient acuity and volumes.
Net income for Q2 2025 was $39.3M, compared to a net loss of $153M in Q2 2024, reflecting improved operations and absence of prior year impairment charges.
The company completed its exit from most office-based practices, focusing on hospital-based and maternal-fetal medicine services.
Ongoing cost management and stable payer mix contributed to improved financial performance and a strengthened balance sheet.
Financial highlights
Same-unit revenue grew 6.4% year-over-year, with NICU days up 6% and strong RCM collections.
Q2 2025 diluted EPS was $0.46, compared to a loss of $1.84 in Q2 2024; adjusted EPS was $0.53, up from $0.34.
Operating cash flow reached $138M in Q2, up from $109M in the prior year, driven by higher earnings and improved working capital.
Ended the quarter with $225M in cash and net debt just over $380M; net leverage slightly above 1.5x adjusted EBITDA.
Six-month net revenue was $927.2M, down 7.2% year-over-year, with net income of $60M versus a net loss of $149M in the prior year.
Outlook and guidance
Full-year adjusted EBITDA guidance raised and narrowed to $245M–$255M, reflecting strong Q2 performance and improved visibility for the second half.
Adjusted EBITDA expected to be ratable in Q3 and Q4; cash balance projected at $350M–$400M by year-end 2025 absent other activities.
Margins expected to remain stable through 2025, with tougher comps anticipated in the second half.
Management expects funds from operations, cash on hand, and available credit to be sufficient for all obligations for at least the next 12 months.
The company anticipates continued compliance with financial covenants throughout 2025.
Next Pediatrix Medical Group earnings date

Next Pediatrix Medical Group earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage